Why should I perform a Freedom to Operate (FTO) analysis before launching my product?

Conducting a freedom to operate analysis is essential before launching a product to identify potential patent risks. This process helps assess infringement threats and enables informed decisions, promoting legal compliance and risk mitigation.

Read more about Why should I perform a Freedom to Operate (FTO) analysis before launching my product?

CASE BRIEF: FMC Corporation & Ors. vs. Natco Pharma Limited

The Delhi High Court analysed whether Natco Pharma’s process infringed FMC Corporation’s patented method for producing chlorantraniliprole. The court, relying on expert opinions, found key differences in process steps and chemical agents, leading to a decision of non-infringement.

Read more about CASE BRIEF: FMC Corporation & Ors. vs. Natco Pharma Limited

No single leader in 5G tech, finds USPTO; DHC sets up IPR Bench, notifies final rules and more patent news.

This week’s bulletin highlights the absence of a single leader in 5G technology as found by the USPTO and the notification of key IPR rules by the Delhi High Court. It also covers major international patent disputes and recent legal updates relevant to patent enforcement and policy.

Read more about No single leader in 5G tech, finds USPTO; DHC sets up IPR Bench, notifies final rules and more patent news.

Purdue University accuses Google of patent infringement, India triples number of patent grants and more

India has significantly increased its patent grants, while Purdue University has filed a patent infringement suit against Google. Other updates include Gilead’s settlement on HIV drug patents, BlackBerry’s patent sale, and a new trial in the Apple-WiLAN case.

Read more about Purdue University accuses Google of patent infringement, India triples number of patent grants and more

SC extends limitation period again, Natco Pharma obtains patent license from Medicines Patent Pool and other patent news

This week’s patent news highlights the Supreme Court’s extension of limitation periods and Natco Pharma’s new license for Molnupiravir. Updates also include important patent litigation developments in India and globally.

Read more about SC extends limitation period again, Natco Pharma obtains patent license from Medicines Patent Pool and other patent news